Corinna Pade

3.5k total citations
15 papers, 333 citations indexed

About

Corinna Pade is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Corinna Pade has authored 15 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Virology and 6 papers in Immunology. Recurrent topics in Corinna Pade's work include HIV Research and Treatment (7 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Corinna Pade is often cited by papers focused on HIV Research and Treatment (7 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Corinna Pade collaborates with scholars based in United Kingdom, Australia and United States. Corinna Pade's co-authors include Áine McKnight, Hanna Dreja, Nidia M. M. Oliveira, David Beach, Matthias T. Dittmar, Viola Borgdorff, Kelly M. Cheney, Cleo L. Bishop, Li Liu and Adam Jarmuz and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Corinna Pade

14 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Corinna Pade United Kingdom 10 131 120 117 86 41 15 333
Todd Bradley United States 11 337 2.6× 261 2.2× 123 1.1× 180 2.1× 72 1.8× 30 707
Andrea Rubio Argentina 11 78 0.6× 127 1.1× 161 1.4× 62 0.7× 99 2.4× 17 365
Maria Cowen United States 10 168 1.3× 77 0.6× 59 0.5× 77 0.9× 20 0.5× 16 268
Bastian Grewe Germany 11 188 1.4× 49 0.4× 179 1.5× 75 0.9× 25 0.6× 12 312
Millán Ortiz Switzerland 9 125 1.0× 92 0.8× 212 1.8× 154 1.8× 128 3.1× 10 357
Nina Hertoghs United States 7 106 0.8× 72 0.6× 91 0.8× 213 2.5× 53 1.3× 17 346
Rebecca Batorsky United States 10 79 0.6× 66 0.6× 99 0.8× 74 0.9× 23 0.6× 22 254
Dominique Van Looveren Belgium 7 127 1.0× 196 1.6× 33 0.3× 39 0.5× 43 1.0× 11 305
Megan A. O’Connor United States 11 92 0.7× 87 0.7× 139 1.2× 161 1.9× 140 3.4× 26 361
Mir M. Khalid United States 10 162 1.2× 249 2.1× 28 0.2× 49 0.6× 40 1.0× 16 425

Countries citing papers authored by Corinna Pade

Since Specialization
Citations

This map shows the geographic impact of Corinna Pade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corinna Pade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corinna Pade more than expected).

Fields of papers citing papers by Corinna Pade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corinna Pade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corinna Pade. The network helps show where Corinna Pade may publish in the future.

Co-authorship network of co-authors of Corinna Pade

This figure shows the co-authorship network connecting the top 25 collaborators of Corinna Pade. A scholar is included among the top collaborators of Corinna Pade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corinna Pade. Corinna Pade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chambers, Emma S., Giulia Vivaldi, David A. Jolliffe, et al.. (2024). Influence of individuals’ determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination. npj Vaccines. 9(1). 87–87. 6 indexed citations
2.
Miyashita, Lisa, Sean Semple, Joseph M. Gibbons, et al.. (2023). Curbside particulate matter and susceptibility to SARS–CoV-2 infection. SHILAP Revista de lepidopterología. 2(4). 100141–100141. 3 indexed citations
3.
Altmann, Daniel M., Catherine J. Reynolds, George Joy, et al.. (2023). Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity. Nature Communications. 14(1). 5139–5139. 20 indexed citations
4.
Kele, Beatrix, Kathryn Harris, Jon M. Bible, et al.. (2022). Generation of Novel Severe Acute Respiratory Syndrome Coronavirus 2 Variants on the B.1.1.7 Lineage in 3 Patients With Advanced Human Immunodeficiency Virus-1 Disease. Clinical Infectious Diseases. 75(11). 2016–2018. 18 indexed citations
5.
Vivaldi, Giulia, David A. Jolliffe, Sian Faustini, et al.. (2022). Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study. The Journal of Infectious Diseases. 226(11). 1903–1908. 9 indexed citations
6.
Gibbons, Joseph M., Corinna Pade, Wenhao Li, et al.. (2022). The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19. Frontiers in Immunology. 12. 813300–813300. 7 indexed citations
7.
Jolliffe, David A., Giulia Vivaldi, Emma S. Chambers, et al.. (2022). Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial. Nutrients. 14(18). 3821–3821. 26 indexed citations
8.
Mangan, Niamh E., Corinna Pade, San Sui Lim, et al.. (2017). Interferon epsilon promotes HIV restriction at multiple steps of viral replication. Immunology and Cell Biology. 95(5). 478–483. 30 indexed citations
9.
Pham, Son, Thibault Tabarin, Megan Garvey, et al.. (2015). Cryo-electron microscopy and single molecule fluorescent microscopy detect CD4 receptor induced HIV size expansion prior to cell entry. Virology. 486. 121–133. 13 indexed citations
10.
Dreja, Hanna, Corinna Pade, Lei Chen, & Áine McKnight. (2015). CD4 binding site broadly neutralizing antibody selection of HIV-1 escape mutants. Journal of General Virology. 96(7). 1899–1905. 8 indexed citations
11.
Ogunkolade, Babatunji W, et al.. (2014). Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses. Retrovirology. 11(1). 3–3. 20 indexed citations
12.
13.
Liu, Li, Nidia M. M. Oliveira, Kelly M. Cheney, et al.. (2011). A whole genome screen for HIV restriction factors. Retrovirology. 8(1). 94–94. 106 indexed citations
14.
15.
Machín, Félix, et al.. (2004). Condensin Regulates rDNA Silencing by Modulating Nucleolar Sir2p. Current Biology. 14(2). 125–130. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Todd Bradley Breakdown of academic impact, for papers by Andrea Rubio Breakdown of academic impact, for papers by Maria Cowen Breakdown of academic impact, for papers by Bastian Grewe Breakdown of academic impact, for papers by Millán Ortiz Breakdown of academic impact, for papers by Nina Hertoghs Breakdown of academic impact, for papers by Rebecca Batorsky Breakdown of academic impact, for papers by Dominique Van Looveren Breakdown of academic impact, for papers by Megan A. O’Connor Breakdown of academic impact, for papers by Mir M. Khalid
Rankless by CCL
2026